Kurt Bjerregaard Stage

1.4k total citations
39 papers, 1.1k citations indexed

About

Kurt Bjerregaard Stage is a scholar working on Pharmacology, Psychiatry and Mental health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kurt Bjerregaard Stage has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 17 papers in Psychiatry and Mental health and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kurt Bjerregaard Stage's work include Treatment of Major Depression (20 papers), Bipolar Disorder and Treatment (9 papers) and Electroconvulsive Therapy Studies (7 papers). Kurt Bjerregaard Stage is often cited by papers focused on Treatment of Major Depression (20 papers), Bipolar Disorder and Treatment (9 papers) and Electroconvulsive Therapy Studies (7 papers). Kurt Bjerregaard Stage collaborates with scholars based in Denmark, Canada and United Kingdom. Kurt Bjerregaard Stage's co-authors include Thomas Middelboe, Charlotta Pisinger, Rie Lambæk Mikkelsen, P. Kragh‐Sørensen, Malene Grubbe Hildebrandt, Lirio S. Covey, Per Bech, Ewout W. Steyerberg, Jan Passchier and N.P.V. Nair and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of Affective Disorders.

In The Last Decade

Kurt Bjerregaard Stage

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt Bjerregaard Stage Denmark 20 277 243 225 207 195 39 1.1k
Veeraindar Goli United States 17 384 1.4× 43 0.2× 400 1.8× 164 0.8× 97 0.5× 25 1.6k
Annabel Price United Kingdom 18 97 0.4× 112 0.5× 300 1.3× 164 0.8× 67 0.3× 41 1.1k
Salem Bensasi United States 15 409 1.5× 57 0.2× 397 1.8× 76 0.4× 244 1.3× 20 946
Moise Khayrallah United States 13 190 0.7× 198 0.8× 480 2.1× 86 0.4× 322 1.7× 15 2.1k
Raphael J. Leo United States 22 166 0.6× 55 0.2× 351 1.6× 103 0.5× 50 0.3× 54 1.3k
Amir Zaimovic Italy 22 251 0.9× 67 0.3× 160 0.7× 45 0.2× 146 0.7× 27 1.2k
Sarah K. Rivelli United States 16 64 0.2× 93 0.4× 123 0.5× 98 0.5× 161 0.8× 23 1.4k
Joanna K. Seirup United States 16 118 0.4× 55 0.2× 191 0.8× 194 0.9× 203 1.0× 21 807
Robert Suchting United States 20 149 0.5× 47 0.2× 182 0.8× 95 0.5× 164 0.8× 100 1.3k
Roy R. Reeves United States 24 353 1.3× 36 0.1× 537 2.4× 88 0.4× 77 0.4× 107 1.6k

Countries citing papers authored by Kurt Bjerregaard Stage

Since Specialization
Citations

This map shows the geographic impact of Kurt Bjerregaard Stage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Bjerregaard Stage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Bjerregaard Stage more than expected).

Fields of papers citing papers by Kurt Bjerregaard Stage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Bjerregaard Stage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Bjerregaard Stage. The network helps show where Kurt Bjerregaard Stage may publish in the future.

Co-authorship network of co-authors of Kurt Bjerregaard Stage

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Bjerregaard Stage. A scholar is included among the top collaborators of Kurt Bjerregaard Stage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Bjerregaard Stage. Kurt Bjerregaard Stage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glintborg, Dorte, et al.. (2018). Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS. Endocrine Connections. 7(3). 479–489. 8 indexed citations
2.
Licht, Rasmus Wentzer, Kjeld Andersen, Tore Bjerregaard Stage, et al.. (2016). Diagnostic Conversion to Bipolar Disorder in Unipolar Depressed Patients Participating in Trials on Antidepressants. European Psychiatry. 40. 76–81. 13 indexed citations
3.
Bech, Per, Kurt Bjerregaard Stage, J. K. Larsen, Per Vestergaard, & L. F. Gram. (2012). The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine. Journal of Affective Disorders. 140(3). 253–259. 6 indexed citations
4.
Stage, Kurt Bjerregaard, et al.. (2008). [Treatment of psychotic depression].. PubMed. 170(46). 3753–5. 1 indexed citations
5.
Sørensen, L., Bent Nielsen, Kurt Bjerregaard Stage, Kim Brøsen, & Per Damkier. (2008). Implementation of a rational pharmacotherapy intervention for inpatients at a psychiatric department. Nordic Journal of Psychiatry. 62(3). 242–249. 3 indexed citations
6.
Videbech, Poul, Niels Damsbo, Hans Henrik Jensen, et al.. (2007). Referenceprogram for unipolar depression hos voksne. University of Southern Denmark Research Portal (University of Southern Denmark). 1–138. 15 indexed citations
7.
Stage, Kurt Bjerregaard, et al.. (2006). Depression in COPD ? management and quality of life considerations. International Journal of COPD. 1(3). 315–320. 39 indexed citations
8.
Stage, Kurt Bjerregaard, et al.. (2005). Orthostatic side effects of clomipramine and moclobemide during treatment for depression. Nordic Journal of Psychiatry. 59(4). 298–301. 9 indexed citations
9.
Hildebrandt, Malene Grubbe, Ewout W. Steyerberg, Kurt Bjerregaard Stage, Jan Passchier, & P. Kragh‐Sørensen. (2003). The Danish University Antidepressant Group: Are gender differences important for the clinical effects of antidepressants?. American Journal of Psychiatry. 16 indexed citations
10.
Wang, August G., et al.. (2003). Comorbid personality disorder predicts suicide after major depression: a 10‐year follow‐up. Acta Psychiatrica Scandinavica. 107(6). 436–440. 43 indexed citations
11.
Hildebrandt, Malene Grubbe, et al.. (2003). Gender Differences in Severity, Symptomatology and Distribution of Melancholia in Major Depression. Psychopathology. 36(4). 204–212. 38 indexed citations
12.
Wang, August G., et al.. (2003). Comorbid personality disorder predicts suicide after major depression: a 10-year follow-up. Acta Psychiatrica Scandinavica. 107(6). 436–440. 13 indexed citations
13.
Stage, Kurt Bjerregaard, et al.. (2002). Age‐related adverse drug reactions to clomipramine. Acta Psychiatrica Scandinavica. 105(1). 55–59. 11 indexed citations
14.
Stage, Kurt Bjerregaard, Per Bech, P. Kragh‐Sørensen, N.P.V. Nair, & Cornelius Katona. (2001). Differences in symptomatology and diagnostic profile in younger and elderly depressed inpatients. Journal of Affective Disorders. 64(2-3). 239–248. 19 indexed citations
15.
Stage, Kurt Bjerregaard, et al.. (2001). ICD-10 criteria for depression in general practice. Journal of Affective Disorders. 65(2). 191–194. 22 indexed citations
16.
Lund, C. E., et al.. (1999). Interrater reliability of a Danish version of the Morgan Russell scale for assessment of anorexia nervosa. International Journal of Eating Disorders. 25(1). 105–108. 6 indexed citations
17.
Stage, Kurt Bjerregaard, et al.. (1998). Are in‐patient depressives more often of the melancholic subtype?. Acta Psychiatrica Scandinavica. 98(6). 432–436. 21 indexed citations
18.
Bech, Per, Kurt Bjerregaard Stage, N.P.V. Nair, et al.. (1997). The Major Depression Rating Scale (MDS). Inter-rater reliability and validity across different settings in randomized moclobemide trials. Journal of Affective Disorders. 42(1). 39–48. 40 indexed citations
19.
20.
Kragh‐Sørensen, P., et al.. (1995). Moclobemide Versus Clomipramine in Depressed Patients in General Practice. A Randomized, Double-Blind, Parallel, Multicenter Study. Journal of Clinical Psychopharmacology. 15(4 Suppl 2). 24S–30S. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Veeraindar Goli Breakdown of academic impact, for papers by Annabel Price Breakdown of academic impact, for papers by Salem Bensasi Breakdown of academic impact, for papers by Moise Khayrallah Breakdown of academic impact, for papers by Raphael J. Leo Breakdown of academic impact, for papers by Amir Zaimovic Breakdown of academic impact, for papers by Sarah K. Rivelli Breakdown of academic impact, for papers by Joanna K. Seirup Breakdown of academic impact, for papers by Robert Suchting Breakdown of academic impact, for papers by Roy R. Reeves
Rankless by CCL
2026